ConductScience.org, home

Paper25317186

Effect of Skimmed Milk on the Absorption and Metabolism of5-Fluorouracil (5-FU) in Animals.

Ahmad M and 5 others. Iran J Pharm Res, 2012. Cited by 0 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Effect of Skimmed Milk on the Absorption and Metabolism of5-Fluorouracil (5-FU) in Animals. Papers, record 25317186. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/25317186

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Effect of Skimmed Milk on the Absorption and Metabolism of5-Fluorouracil (5-FU) in Animals.
PubMed
Journal
Iran J Pharm Res
PubMed
Year
2012
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
0
iCite
Relative citation ratio, by iCite
0
iCite
Revised in PubMed
2021-10-21
PubMed

Authors6

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Ahmad MMaqsood
2Ghumman SAShazia Akram
3Sher AAlamgeer
4Sharif TTanveer
5Sher MMuhammad
6Abbas TTahir

Source PubMed

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

References22

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
110,499,595The oral fluoropyrimidines in cancer chemotherapy.Clin Cancer Res1999https://conductscience.org/library/papers/10499595PubMed
214,254,828EFFECTIVENESS AND TOXICITY OF PROLONGED INFUSIONS OF 5-FLUOROURACIL IN THE TREATMENT OF CANCER.Am J Med Sci1965https://conductscience.org/library/papers/14254828PubMed
34,609,602Clinical pharmacology of oral and intravenous 5-fluorouracil (NSC-19893).Cancer Chemother Rep1974https://conductscience.org/library/papers/4609602PubMed
47,388,790Pharmacokinetics of 5-fluorouracil administered orally, by rapid intravenous and by slow infusion.Cancer Res1980https://conductscience.org/library/papers/7388790PubMed
516,173,332Prevention of oral mucositis due to 5-fluorouracil treatment with oral cryotherapy.J Natl Med Assoc2005https://conductscience.org/library/papers/16173332PubMed
62,293,556
Relationship between dihydropyrimidine dehydrogenase activity and plasma 5-fluorouracil levels with evidence for circadian variation of enzyme activity and plasma drug levels in cancer patients receiving 5-fluorouracil by protracted continuous infusion.
Cancer Res1990https://conductscience.org/library/papers/2293556PubMed
73,049,954Fluorouracil: biochemistry and pharmacology.J Clin Oncol1988https://conductscience.org/library/papers/3049954PubMed
811,585,968The evolution of fluoropyrimidine therapy: from intravenous to oral.Oncologist2001https://conductscience.org/library/papers/11585968PubMed
93,280,741A randomized trial of fluorouracil and folinic acid in patients with metastatic colorectal carcinoma.J Clin Oncol1988https://conductscience.org/library/papers/3280741PubMed
10465,283Plasma levels of 5-fluorouracil after oral and intravenous administration in cancer patients.Br J Clin Pharmacol1979https://conductscience.org/library/papers/465283PubMed
1111,291,832The oral fluorinated pyrimidines.Invest New Drugs2001https://conductscience.org/library/papers/11291832PubMed
1211,709,571Fluorouracil (5FU) pharmacokinetics in 5FU prodrug formulations with a dihydropyrimidine dehydrogenase inhibitor.J Clin Oncol2001https://conductscience.org/library/papers/11709571PubMed
131,406,460Antibacterial effect of bovine milk antibody against Escherichia coli in a mouse indigenous infection model.Med Microbiol Immunol1992https://conductscience.org/library/papers/1406460PubMed
143,920,827[Prophylactic effect of enteral feeding preparations during the chemotherapy of oncology patients].Vopr Pitan1985https://conductscience.org/library/papers/3920827PubMed
153,829,006Clinical pharmacokinetics of 5-fluorouracil and its metabolites in plasma, urine, and bile.Cancer Res1987https://conductscience.org/library/papers/3829006PubMed
16678,346Fluorouracil therapy in patients with carcinoma of the large bowel: a pharmacokinetic comparison of various rates and routes of administration.Clin Pharmacokinet1978https://conductscience.org/library/papers/678346PubMed
172,926,468A prospective randomized comparison of continuous infusion fluorouracil with a conventional bolus schedule in metastatic colorectal carcinoma: a Mid-Atlantic Oncology Program Study.J Clin Oncol1989https://conductscience.org/library/papers/2926468PubMed
181,512,248Purification and characterization of dihydropyrimidine dehydrogenase from human liver.J Biol Chem1992https://conductscience.org/library/papers/1512248PubMed
1912,378,555Simultaneous HPLC determination of 5-fluorouracil and its metabolites in plasma of cancer patients.Biomed Chromatogr2002https://conductscience.org/library/papers/12378555PubMed
208,636,939Experimental endogenous septicaemia caused by Klebsiella pneumoniae and Escherichia coli in mice.J Med Microbiol1996https://conductscience.org/library/papers/8636939PubMed

See all 22 references

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
DPYD1,806PubTator's text mininghttps://conductscience.org/library/genes/1806

Source NCBI Gene

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Cited by
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/25317186

GET https://conductscience.org/api/papers/v1/25317186/references?page=2